In qualsiasi momento della giornata, preferibilmente a digiuno
Neuropharmacology 38:383394 Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, El Mlili N, Boix J, Agusti A, Felipo V (2009) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy
Peptide-based GLP-1/glucagon co-agonists: a double-edged sword to combat diabesity
Once approved by a provider, your prescription is sent directly to the pharmacy for fulfillment
Also worth keeping in mind: Wegovy, like other GLP-1s, isn't a one-and-done drug that you stop taking once you lose weight
Second, as a stimulant, long-term use is generally avoided to prevent potential strain on the cardiovascular system and to minimize the risk of dependency